Exploring how miR-133a-3p functions as a molecular brake on liver cancer growth and its potential as a diagnostic tool and therapeutic target.
Discover how plasmid FGF-2 magnetic chitosan gelatin microspheres are revolutionizing mesenchymal stem cell therapy through controlled growth factor delivery.
Exploring how impaired autophagy creates cisplatin-resistant lung cancer cells and potential therapeutic strategies to overcome this resistance.
Discover how LINC00599, miR-212-5p, and BASP1 form a critical axis in COPD progression through cigarette smoke-induced apoptosis and inflammation.
Discover how umbilical cord-derived stem cells are engineered with IL-24 to target and destroy glioblastoma tumors while sparing healthy tissue.
Thiosemicarbazone-based drugs show promise in halting gastric cancer tumor growth and spread through selective proliferation inactivation.
Discover how fluvastatin, a common cholesterol drug, enhances the anticancer effects of vorinostat in renal cell carcinoma through metabolic-epigenetic synergy.
Discover how p62/IMP2-2 protein enables hepatocellular carcinoma to evade apoptosis through IGF2-independent pathways, offering new therapeutic targets.
Exploring how Nutlin-3 reactivates p53's cancer-fighting power in rhabdomyosarcoma, offering hope for children with relapsed or aggressive disease.
Discover how knocking down BDNF in B-cell lymphoma cells induces cell cycle arrest and apoptosis, offering new therapeutic strategies.